Indietro
YESINTEK conc perf 130 mg/26ml (ec 05/26)
Medius AG
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | |
|---|---|---|---|---|---|---|
YESINTEK conc perf 130 mg/26ml flac 26 mlAvosano Industrie Service AG | 1170743 | CHF 1540.15 | Cat. B | SL / 10% |
Articoli alternativi senza carenza di approvvigionamento segnalata
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | Relazione farmaceutica | |
|---|---|---|---|---|---|---|---|
STELARA conc perf 130 mg/26ml flacJanssen-Cilag AG | 7136323 | CHF 1540.15 | Cat. B | SL / 10% | Equivalente | ||
WEZENLA conc perf 130 mg/26ml flac 26 mlAmgen Switzerland AG | 1161098 | CHF 1540.15 | Cat. B | SL / 10% | Equivalente | ||
USTEKINUMAB Spirig HC conc perf 130 mg/26mlSpirig HealthCare AG | 1155620 | CHF 1252.65 | Cat. B | SL / 10% | Equivalente | ||
STEQEYMA conc perf 130 mg/26ml flac 26 mlAvosano Industrie Service AG | 1165564 | CHF 1540.15 | Cat. B | SL / 10% | Equivalente | ||
IMULDOSA conc perf 130 mg/26ml flac 26 mlAvosano AG | 1165808 | CHF 1252.65 | Cat. B | SL / 10% | Equivalente | ||
PYZCHIVA conc perf 130 mg/26ml flac 26 mlSandoz Pharmaceuticals AG | 1182740 | CHF 1540.15 | Cat. B | SL / 10% | Equivalente | ||
STELARA sol inj 45 mg/0.5ml ser prê 0.5 mlJanssen-Cilag AG | 4756574 | CHF 1540.15 | Cat. B | SL / 10% | Forma | ||
STELARA sol inj 90 mg/ml ser pré 1 mlJanssen-Cilag AG | 4756580 | CHF 1540.15 | Cat. B | SL / 10% | Forma | ||
STELARA sol inj 45 mg/0.5ml flacJanssen-Cilag AG | 7227936 | CHF 1540.15 | Cat. B | SL / 10% | Forma | ||
STELARA sol inj 45 mg/0.5ml stylo prérempli 0.5 mlJanssen-Cilag AG | 1103038 | CHF 1540.15 | Cat. B | SL / 10% | Forma |